<?xml version="1.0" encoding="UTF-8"?>
<ref id="B86-ijms-22-01591">
 <label>86.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zeng</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yin</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Jin</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>You</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>miR-129-5p targets Wnt5a to block PKC/ERK/NF-kappaB and JNK pathways in glioblastoma</article-title>
  <source>Cell Death Dis.</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>394</fpage>
  <pub-id pub-id-type="doi">10.1038/s41419-018-0343-1</pub-id>
  <?supplied-pmid 29531296?>
  <pub-id pub-id-type="pmid">29531296</pub-id>
 </element-citation>
</ref>
